Short Interest in Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (OTCMKTS:SFOSF) Rises By 226.6%

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (OTCMKTS:SFOSF) was the target of a large growth in short interest in the month of January. As of January 15th, there was short interest totaling 983,500 shares, a growth of 226.6% from the December 31st total of 301,151 shares. Based on an average trading volume of 1,580 shares, the days-to-cover ratio is presently 622.5 days. Based on an average trading volume of 1,580 shares, the days-to-cover ratio is presently 622.5 days.

Shanghai Fosun Pharmaceutical (Group) Stock Performance

OTCMKTS:SFOSF opened at $2.86 on Friday. Shanghai Fosun Pharmaceutical has a 52-week low of $1.62 and a 52-week high of $3.50. The business’s fifty day moving average is $2.99 and its 200 day moving average is $2.92.

About Shanghai Fosun Pharmaceutical (Group)

Shanghai Fosun Pharmaceutical (Group) Co, Ltd. is a China‐based healthcare company and a core subsidiary of Fosun International. The company operates across drug manufacturing, distribution and retail services, and health management. Its product portfolio includes generic and proprietary small‐molecule drugs, bio‐pharmaceuticals, vaccines and traditional Chinese patent medicines. Through integrated R&D capabilities and strategic partnerships, Fosun Pharmaceutical pursues innovation across therapeutic areas such as oncology, cardiovascular, metabolic and infectious diseases.

The pharmaceutical manufacturing segment encompasses chemical pharmaceuticals, Chinese patent medicines and biological products, while the distribution arm manages one of the largest drug distribution networks in China, supplying hospitals, clinics and retail pharmacies.